Posted by Michael Wonder on 22 Jan 2024
NICE issues draft guidance for use of remdesivir and also for tixagevimab-cilgavimab for treatment of COVID-19
18 January 2024 - Draft guidance for public consultation has been published by NICE.
The recommendations are draft and could change following public consultation.
SMC has had direct input into the decision-making committee that produced the draft guidance. The final published advice will have the same status for health board consideration as other SMC advice on new medicines.
